Author:
Perlis Nathan,Krahn Murray,Alibhai Shabbir,Finelli Antonio,Ritvo Paul,Bremner Karen E.,Kulkarni Girish
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference39 articles.
1. Jemal, A., Bray, F., Centre, M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61, 69–90.
2. Fokdal, L., Høyer, M., Meldgaard, P., & von der Maase, H. (2004). Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiotherapy and Oncology, 72(2), 139–145. doi: 10.1016/j.radonc.2004.05.006 .
3. Efstathiou, J. A., Bae, K., Shipley, W. U., Kaufman, D. S., Hagan, M. P., Heney, N. M., et al. (2009). Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. Journal of Clinical Oncology, 27(25), 4055–4061. doi: 10.1200/JCO.2008.19.5776 .
4. Grossman, H. B., Natale, R. B., Tangen, C. M., Speights, V. O., Vogelzang, N. J., Trump, D. L., et al. (2003). Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. The New England Journal of Medicine, 349(9), 859–866. doi: 10.1056/NEJMoa022148 .
5. Nieder, A. M., Brausi, M., Lamm, D., O’Donnell, M., Tomita, K., Woo, H., et al. (2005). Management of stage T1 tumors of the bladder: International Consensus Panel. Urology, 66(6), 108–125.